| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.17 | 0.001 |